Hyperuricemia Trials in Shanghai, China
Conditions / Hyperuricemia / Shanghai, China
Hyperuricemia is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06501534 | A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects | COMPLETED | PHASE2 |
| NCT02338323 | Compare the Renal Protective Effects of Febuxostat and Benzbromarone | COMPLETED | NA |
| NCT02944214 | Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients | UNKNOWN | NA |
| NCT05504083 | Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients | COMPLETED | PHASE2 |
| NCT03185793 | Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia | COMPLETED | PHASE2 |
| NCT06678581 | SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects | COMPLETED | PHASE1 |
| NCT02338128 | The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients | COMPLETED | — |
| NCT03691688 | The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease（AURORA） | UNKNOWN | — |
| NCT00607152 | Rasburicase (Fasturtec) Registration Trial | TERMINATED | PHASE3 |
| NCT06629376 | Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia | RECRUITING | PHASE1 |